Results 111 to 120 of about 12,566,431 (163)

A novel snake venom C-type lectin-like protein modulates blood coagulation by targeting von Willebrand factor and coagulation factor IX. [PDF]

Sci Rep
Zeng FY, Ji RS, Yu XQ, Li YN, Zhang QY, Sun QY.   +5 more
europepmc   +1 more source

A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene. [PDF]

Thromb J
Wei X, Zhang H, Chen W, Zhang J, Dai J.
europepmc   +1 more source

Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.

Blood
Lee K, Chau JQ, Suber YB, Sternberg AR, Pishko AM, George LA, Bhoj VG, Doshi BS, Samelson-Jones BJ.   +8 more
europepmc   +1 more source

The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia B. [PDF]

J Manag Care Spec Pharm
Sarker J, Tice JA, Rind DM, Pearson SD, Walton SM.   +4 more
europepmc   +1 more source

Assessing health care resource use, outcomes, and costs among Medicaid beneficiaries receiving factor IX prophylaxis for hemophilia B. [PDF]

J Manag Care Spec Pharm
Pauly N, Burrell A, Drelich D, Zhang X, Thiruvillakkat K, Nysenbaum J, Fiori A, Yan S.   +7 more
europepmc   +1 more source

Correlation of antigen expression with epigenetic modifications after rAAV delivery of a human factor IX variant in mice and rhesus macaques. [PDF]

Mol Ther
Pekrun K, Stephens CJ, Gonzalez-Sandoval A, Goswami A, Zhang F, Tarantal AF, Blouse G, Kay MA.   +7 more
europepmc   +1 more source

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

Proceedings of the National Academy of Sciences of the United States of America, 1995
Yifan Dai, E. Schwarz, D. Gu, Wei Zhang, N. Sarvetnick, Inder M. Verma   +5 more
semanticscholar   +1 more source

Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction. [PDF]

J Thromb Haemost
Coyle CW, Knight KA, Brown HC, George SN, Denning G, Branella GM, Childers KC, Spiegel PC, Spencer HT, Doering CB.   +9 more
europepmc   +1 more source

Complete F9 Gene Deletion, Duplication, and Triplication Rearrangements: Implications for Factor IX Expression and Clinical Phenotypes. [PDF]

Thromb Haemost
Ma Y, Li Y, Sun J, Liang Q, Wu R, Ding Q, Dai J.   +6 more
europepmc   +1 more source

Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany. [PDF]

Res Pract Thromb Haemost
Bidlingmaier C, Heller C, Langer F, Miesbach W, Scholz U, Oldenburg J, Nüesch E, Palmborg H, Santagostino E, Tiede A.   +9 more
europepmc   +1 more source